title: [Totally implantable venous access ports by cephalic vein cut-down for patients receiving chemotherapy].
abstract: BACKGROUND
  The use of an implantable room has become indispensable in the clinical practice for the cancer patients. The increasing use of these devices was associated with a greater incidence of complications.
  
  
  OBJECTIVE
  To verify the feasibility of the cephalic vein cut-down technique for placement of venous access devices.
  
  
  METHODS
  A prospective study of 58 port placements was performed at our department of general surgery. The surveillance of devices was collectively insured by the operator and by the oncologists.
  
  
  RESULTS
  The indication for implantation was the infusion of intravenous chemotherapy in patients with colorectal cancer in 55.1% cases and breast cancer in 27.5%. The specific complication rate was 7%. The cephalic vein cut-down approach was used successful in 45 (77.5%) patients. When the cephalic vein could not be used, a percutaneous technique was employed using the subclavian vein in 22.4% of the patients.
  
  
  CONCLUSIONS
  Cephalic vein cut-down technique should be considered a safe and feasible approach for placement of venous access devices.
authors.affiliation: Service de Chirurgie, Hopital La Rabta, Tunis, Tunisie.
authors.forename: Sofiene
authors.initials: S
authors.lastname: Ayadi
authors.forename: Rchid
authors.initials: R
authors.lastname: Ksantini
authors.forename: Houcine
authors.initials: H
authors.lastname: Maghrebi
authors.forename: Amine
authors.initials: A
authors.lastname: Daghfous
authors.forename: Mona
authors.initials: M
authors.lastname: Ayadi
authors.forename: Fadhel
authors.initials: F
authors.lastname: Fteriche
authors.forename: Haikel
authors.initials: H
authors.lastname: Bedioui
authors.forename: Faouzi
authors.initials: F
authors.lastname: Chebbi
authors.forename: Adel
authors.initials: A
authors.lastname: Amous
authors.forename: Mohamed
authors.initials: M
authors.lastname: Jouini
authors.forename: Montassar
authors.initials: M
authors.lastname: Kacem
authors.forename: Amel
authors.initials: A
authors.lastname: Mezlini
authors.forename: Zoubeir
authors.initials: Z
authors.lastname: Ben Safta
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D016121:Brachiocephalic Veins; D002405:Catheterization, Central Venous; D002408:Catheters, Indwelling; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D016748:Venous Cutdown
chemical_list: D000970:Antineoplastic Agents